Medcaw Investments Plc announced that it has appointed Mr. Charles Ainslie (“Charlie”) Wood and Marcus Yeoman as Non-executive Directors of the Company with immediate effect, furthermore Daniel Maling and Fungai Ndoro have stepped down from the Board of the Company to focus on other projects. The Company would like to thank Daniel and Fungai for their contribution whilst on the Board and would like to wish them all the best in their future endeavours. All director fees will be deferred until the transaction between Medcaw and ATC is completed.

Marcus Yeoman holds 0.18% and Charles Wood holds 6.16% of Medcaw Investments. Charlie Wood is a highly experienced senior corporate finance executive with wide ranging international and capital markets experience. Mr. Wood is a Partner of Orana Corporate LLP, aLondon based FCA regulated corporate advisory and accounting practise working with innovative fast growth companies.

In addition, Mr. Wood holds various non-executive directorships in listed and private companies across natural resources, technology and FMCG. Marcus Yeoman is Chairman and Non-Executive director number of private companies which have engaged him principally to assist them with their growth strategies. His early career started with the formation of three companies in IT infrastructure and distribution, after which he moved into small company broking and corporate work with Rathbone Stockbrokers Limited and Cheviot Capital (Nominees) Limited.

In 2003, Marcus established Springtime Consultants Ltd. and has been acting as a consultant or Non-Executive Director to a number of listed companies and SME ventures over the 20 years.